SEC 13F Intelligence

Capital International Investors / ABT

Capital International Investors’s Abbott Laboratories Position

Does Capital International Investors own Abbott Laboratories (ABT)? Yes — 37.50M shares worth $3.8B (+0.90% of its 13F portfolio) as of Q1 2026, down from 63.23M shares the prior filed quarter.

Position Value
$3.8B
Q1 2026
Shares
37.50M
% of Portfolio
+0.90%
Quarters Held
30
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $1.6BQ4 ’18Q1 ’19: $2.0BQ2 ’19: $3.2BQ3 ’19: $3.8BQ4 ’19: $4.1BQ4 ’19Q1 ’20: $4.4BQ2 ’20: $5.2BQ3 ’20: $6.1BQ4 ’20: $5.9BQ4 ’20Q1 ’21: $6.5BQ2 ’21: $6.5BQ3 ’21: $6.7BQ4 ’21: $7.4BQ4 ’21Q1 ’22: $5.9BQ2 ’22: $5.5BQ3 ’22: $5.1BQ4 ’22: $5.8BQ4 ’22Q1 ’23: $5.7BQ2 ’23: $6.5BQ3 ’23: $6.1BQ4 ’23: $7.1BQ4 ’23Q1 ’24: $8.0BQ2 ’24: $7.5BQ3 ’24: $7.5BQ4 ’24: $7.7BQ4 ’24Q1 ’25: $8.9BQ2 ’25: $8.2BQ3 ’25: $8.3BQ4 ’25: $7.9BQ4 ’25Q1 ’26: $3.8Bfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202637.50M$3.8B+0.90%
Q4 202563.23M$7.9B+1.24%
Q3 202561.61M$8.3B+1.33%
Q2 202560.14M$8.2B+1.41%
Q1 202566.82M$8.9B+1.74%
Q4 202467.97M$7.7B+1.44%
Q3 202465.74M$7.5B+1.44%
Q2 202471.80M$7.5B+1.54%
Q1 202470.18M$8.0B+1.61%
Q4 202364.29M$7.1B+1.59%
Q3 202362.84M$6.1B+1.54%
Q2 202359.18M$6.5B+1.56%
Q1 202356.43M$5.7B+1.47%
Q4 202253.03M$5.8B+1.56%
Q3 202252.23M$5.1B+1.47%
Q2 202250.52M$5.5B+1.49%
Q1 202250.25M$5.9B+1.36%
Q4 202152.40M$7.4B+1.56%
Q3 202156.99M$6.7B+1.54%
Q2 202155.97M$6.5B+1.48%
Q1 202154.56M$6.5B+1.65%
Q4 202053.59M$5.9B+1.60%
Q3 202055.98M$6.1B+1.88%
Q2 202056.71M$5.2B+1.70%
Q1 202055.78M$4.4B+1.80%
Q4 201947.33M$4.1B+1.40%
Q3 201946.00M$3.8B+1.47%
Q2 201938.07M$3.2B+1.28%
Q1 201924.45M$2.0B+0.84%
Q4 201822.68M$1.6B+0.82%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Capital International Investors’s full portfolio or all institutional holders of ABT.